CompletedNCT02918370
Aripiprazole for Alcohol Use in People With Bipolarity
About this title
Read the official source — NCT02918370Medication studyAges 18–65United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
What did participation involve?
Depending on the group, the protocol specifies the study medication (aripiprazole) or a placebo (an inactive comparison treatment).
- Listed locations
- DallasSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateStarted: November 2016
- Recruitment status
- Completed
- Enrollment listed in the registry
- 75
- Sponsor
- University of Texas Southwestern Medical Center
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT02918370
- Official title
Show the full official title
Aripiprazole for Bipolar Disorder and Alcohol Use Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Dallas
Questions about this study
Who is behind this study?
The study sponsor is University of Texas Southwestern Medical Center, a university.
Did this study involve medication?
Yes. The study involved medication, including Aripiprazole and Placebo.
Who was this study for?
Listed age limits: 18 years to 65 years.
